Dr Annette Bosworth was recently quoted in a popular podcast episode as saying, If you wanted to have legs with no hair how would you accomplish that
At present, routine use of dual therapy specifically to improve HF outcomes cannot be recommended because dedicated randomized HF trials are lacking
The episode provides listeners with practical strategies for managing medication-induced weight gain, offering insights on diet, exercise, and potential pharmacological interventions
[DOI] [PubMed] [Google Scholar] [35].Oku A, Ueta K, Arakawa K, Ishihara T, Nawano M, Kuronuma Y, Matsumoto M, Saito A, Tsujihara K, Anai M, Asano T, Kanai Y, Endou H, Diabetes 1999, 48, 1794
10 Pharmacists who are aware of cases of exenatide-associated acute pancreatitis or other serious adverse drug reactions are encouraged to report their findings to MedWatch, the FDAs adverse drug reporting program (www.fda.gov/Safety/MedWatch/ Anti-exenatide Antibodies: In phase III clinical trials, 41% to 49% of patients receiving exenatide developed anti-exenatide antibodies